Robot model
SSi Mantra
Multi-specialty teleoperated surgical robotic system covering general, urological, colorectal, gynecological, and cardiac surgery.
- Manufacturer
- SS Innovations International
- Form factor
- surgical
- Maturity
- commercial
- Lifecycle
- active
- Deployments
- 6
The verified answer
As of Aug 2026, DEPLOY verifies SSi Mantra, a surgical by SS Innovations International (commercial): 6 verified deployments on record. 1 source back the record.
SSi Mantra has 2 FDA 510(k) clearances pending, per the DEPLOY registry.
See all 2 filingsOverview
Multi-specialty teleoperated surgical robotic system covering general, urological, colorectal, gynecological, and cardiac surgery. Commercially deployed internationally with 510(k) pending for U.S. market entry.
Verified vs. claimed
- Maturity stage
- commercial(Commercially deployed with revenue-generating operations.)
- Sources on file
- View all sources →
Key facts
Specialties
Telesurgeries
Cardiac procedures
Data & sources
Web sources
1
1 source backing this record.View all →
Pricing
No verified price is on record for SSi Mantra. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.
Deployments (6)
- SSi Mantra at Indiaoperational
SS Innovations International won 2026 Surgical Robotics Industry Outstanding Company Award.
- SSi Mantra at Continental Hospitaloperational
Continental Hospital, Hyderabad is a study site in the multi-centric SSI Mantra study, performing surgical gastroenterology procedures.
- SSi Mantra at Apex Hospitaloperational
Apex Hospital, Moradabad is a study site in the multi-centric SSI Mantra study, performing minimal access and bariatric surgery as well as gynecology procedures.
Maharashtra's first made-in-India surgical robot SSI Mantra installed at Pune's Noble Hospitals and Research Centre.
- SSi Mantra at Bengaluru, Karnataka, Indiaoperational
Aster CMI Hospital in Bengaluru has performed 500 robotic surgeries using the SSI Mantra system.
First-ever made-in-India surgical robotic system (SSI Mantra) installed at Rajiv Gandhi Cancer Institute and Research Centre (RGCI) in New Delhi.
SSi Mantra on the deployment map
View the global mapWhere SSi Mantra is verified operating. Explore the deployment map by place and type.
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJul 2, 2026
Added to the verified registry
- Deployment verifiedVerifiedDec 1, 2024
at Noble Hospitals and Research Centre
- Deployment verifiedVerifiedJan 1, 2024
at Apex Hospital
- Deployment verifiedVerifiedJan 1, 2024
at Continental Hospital
- Deployment verifiedVerifiedJan 1, 2023
at Bengaluru, Karnataka, India
Regulatory filings (2)
- fda_510kfda 510k · us_fdapending
- fda_510kfda 510k · us_fdapending2025-12-08
Applicant: SS Innovations International
Safety record
No incidents on record for SSi Mantra.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Sources (1)
Common questions
What is SSi Mantra?
How much does SSi Mantra cost?
Is SSi Mantra actually deployed in the real world?
Who makes SSi Mantra?
Where is SSi Mantra deployed?
Can you buy SSi Mantra?
Is SSi Mantra FDA cleared?
What are alternatives to SSi Mantra?
How does SSi Mantra compare to Edison Histotripsy System?
Is SSi Mantra a top surgical?
What is SSi Mantra's maturity stage?
Is SSi Mantra safe?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-07-12
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-07-12
Maturity + lifecycle
Maturity stage: commercial
Lifecycle: active
Architectural position
Cohort: surgical
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for SSi Mantra.Recent coverage
SSi Mantra in third-party press
Attention vs reality over time
Media mentions per month (area) against verified deployment events (dots). A press spike over a flat deployment line is the hype gap, drawn over time.
In the press
Recent coverage mentioning SSi Mantra from third-party publications. Automatically surfaced; not part of the verified registry record.
SS Innovations raises 8.6M ahead of US surgical robot launch
SS Innovations raised 8.6M from investors including Dr. Sudhir Srivastava and Dr. Fred Moll ahead of the US launch of its SSi Mantra surgical robot.
SS Innovations submits robotic system for FDA clearance
SS Innovations submitted its 510(k) premarket notification to the FDA for the SSi Mantra surgical robotic system, seeking clearance for general, urological, colorectal,…
How SS Innovations is expanding robotic surgery's reach
MedTech Dive profiles SS Innovations and founder Dr. Sudhir Srivastava's mission to make robotic surgery affordable and accessible globally with the SSi Mantra system.
Machine-readable surfaces
- Markdown mirror: /models/ssi-mantra.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/models/2cd2961a-8f57-487b-a5e4-faae826ff59f
- Revision history: /models/ssi-mantra/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Video
The honeymoon phase for shiny healthcare tech is over. We are staring down real legislative mandates and the hard reality of workflow adoption. I walked the fl
Reality vs attention
SSi Mantra draws attention at the 37th percentile but verifies reality at the 85th percentile among surgical robots. Hype Gap -48.7, 30th widest among surgical robots.
6-month trend
Analysis
Limited independent press and video coverage to date.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Aug 18, 2026